These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 36618328)
1. Immunological classification of hepatitis B virus-positive hepatocellular carcinoma by transcriptome analysis. Li SW; Han LF; He Y; Wang XS World J Hepatol; 2022 Dec; 14(12):1997-2011. PubMed ID: 36618328 [TBL] [Abstract][Full Text] [Related]
2. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment. Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X Front Public Health; 2022; 10():979933. PubMed ID: 36203656 [TBL] [Abstract][Full Text] [Related]
3. Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell Transcriptomes. Yao J; Li S; Wang X Front Cell Dev Biol; 2021; 9():781848. PubMed ID: 35047498 [No Abstract] [Full Text] [Related]
4. Subtyping of head and neck squamous cell cancers based on immune signatures. Song D; Lyu H; Feng Q; Luo J; Li L; Wang X Int Immunopharmacol; 2021 Oct; 99():108007. PubMed ID: 34332341 [TBL] [Abstract][Full Text] [Related]
5. Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling. Lu Q; Nie R; Luo J; Wang X; You L Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671489 [TBL] [Abstract][Full Text] [Related]
6. Classification of triple-negative breast cancer based on pathway enrichment levels. Liu Q; Wang X Med Oncol; 2023 Apr; 40(6):157. PubMed ID: 37093316 [TBL] [Abstract][Full Text] [Related]
7. Subtyping of sarcomas based on pathway enrichment scores in bulk and single cell transcriptomes. Li S; Liu Q; Zhou H; Lu H; Wang X J Transl Med; 2022 Jan; 20(1):48. PubMed ID: 35093080 [TBL] [Abstract][Full Text] [Related]
8. Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma. Yu X; Chen P; Yi W; Ruan W; Xiong X Front Immunol; 2022; 13():1029872. PubMed ID: 36275676 [TBL] [Abstract][Full Text] [Related]
9. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review. Li B; Yan C; Zhu J; Chen X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Jiang W; Fang W Front Immunol; 2020; 11():1037. PubMed ID: 32547550 [TBL] [Abstract][Full Text] [Related]
10. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics. Wang Y; Wang S; Che Y; Chen D; Liu Y; Shi Y Medicine (Baltimore); 2021 Aug; 100(33):e26917. PubMed ID: 34414947 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma. Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467 [TBL] [Abstract][Full Text] [Related]
12. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma. Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus and hepatocellular carcinoma at the miRNA level. Zhang ZZ; Liu X; Wang DQ; Teng MK; Niu LW; Huang AL; Liang Z World J Gastroenterol; 2011 Jul; 17(28):3353-8. PubMed ID: 21876625 [TBL] [Abstract][Full Text] [Related]
14. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116 [TBL] [Abstract][Full Text] [Related]
15. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma]. Yu Y; Cheng J; Mei CZ; Dai YZ Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255 [TBL] [Abstract][Full Text] [Related]
16. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis. Tang Y; Zhang Y; Hu X Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723 [TBL] [Abstract][Full Text] [Related]
17. Identification of prostate cancer subtypes based on immune signature scores in bulk and single-cell transcriptomes. Chen C; Luo J; Wang X Med Oncol; 2022 Jun; 39(9):123. PubMed ID: 35716212 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma. Jin Y; Lee WY; Toh ST; Tennakoon C; Toh HC; Chow PK; Chung AY; Chong SS; Ooi LL; Sung WK; Lee CG J Transl Med; 2019 Aug; 17(1):273. PubMed ID: 31429776 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype. Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897 [TBL] [Abstract][Full Text] [Related]
20. Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival. Qin SK; Li Q; Ming Xu J; Liang J; Cheng Y; Fan Y; Jiang J; Ye H; Tao H; Li L; Zheng L; Wei Z; Li S; Meng K; Ye B; Sun Y Cancer Sci; 2020 Nov; 111(11):4218-4231. PubMed ID: 32889778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]